Jatcorp ltd
AASX:JAT0.09
AUD
+0.00
(+3.66%)
Jatcorp ltd
ASX:JAT
(Australian Securities Exchange)
Recent
price
0.09
P/E
ratio
24.76
div
yld
- -
ROIC.AI
Capital Structure
AUD
•
in mil. unless spec.Working Capital
AUD
•
in mil. unless spec.Growth Rates
AUD
•
in mil. unless spec.Semi-annual Revenue
AUD
•
in mil. unless spec.Semi-annual Earnings Per Share
AUD
•
in mil. unless spec.Semi-annual Dividends Per Share
AUD
•
in mil. unless spec.- Similar Companies
- Business
- Jatcorp Limited Jatcorp Limited (ASX: JAT) is an Australian manufacturer and distributor of innovative dairy- and plant-based health products and nutritional supplements, specializing in milk powder formulations enriched with functional ingredients such as lactoferrin, immunoglobulins, sialic acid, fructo-oligosaccharides, vitamins, and minerals for consumers ranging from infants to seniors. The company produces and sells core products including cow, goat, and camel milk powder-based formulations; cream and skim milk powders; plant-based meat alternatives such as burgers, meatballs, sausages, minces, and strips; and clinical skincare items like skin brightening serums; offered under prominent brands Neurio, Moroka, Jinvigorate, iOne, Abbeyard, Poupin, and V Meat. Jatcorp operates a vertically integrated model encompassing research, development, production, packaging, and brand management at its 8,000 square meter dry-blending facility under Australian Natural Milk Association Pty Ltd in Melbourne, while providing contract manufacturing services (OEM) to domestic and international partners; it serves pharmacies, specialty retail, e-commerce platforms, and Chinese daigou groups, with primary revenue from China supplemented by sales in Australia, New Zealand, Hong Kong, Vietnam, South Korea, Japan, Southeast Asia, and exploratory efforts in the United States via social commerce. Founded in 2006 and headquartered in Sydney with additional offices in Melbourne and Toorak, Victoria, the company listed on the ASX in 2018 after changing its name from Jatenergy Limited in June 2020 to reflect its pivot to health and nutrition. Recent developments include a strong FY25 start with 25% revenue growth driven by Neurio and Moroka brands, expansion onto Chinese platforms Pinduoduo and JD Worldwide, launch of two new Moroka lactoferrin-based products targeting Southeast Asia demand, entry into Vietnam retail/e-commerce and Hong Kong's Mannings pharmacies, attendance at Vitafoods Asia for distributor sourcing, and strategic plans under new CEO Sunny Liang (appointed early 2024) to prioritize brand building (over 60% of revenue), pursue at least one acquisition of complementary Australian health/nutrition brands for export to China and Southeast Asia, and shift OEM manufacturing to a supporting role amid FY24 revenue up 42% to AUD52.5 million and return to profitability.